A porcine-brain-derived peptide preparation (neurotrophic)
Cognitive researchEvidence: clinical (mixed)Approved in some countries · not US
Approved drug — used here for education. This is an approved/prescription medicine in at least one region; "research"/compounded versions sold as chemicals are a separate, riskier thing. Not medical advice.
What it is
Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from porcine brain, used in some countries for stroke and dementia.
Proposed mechanism
It is proposed to have neurotrophic, neuroprotective effects mimicking endogenous growth factors.1 Trial results are mixed and debated.
State of the evidence
Marketed in numerous countries; efficacy evidence is mixed/contested; not FDA-approved.
Regulatory & status
Approval varies by region; not FDA-approved.
Reconstitution (reference only)
Lab-handling reference only — not a preparation or dosing instruction: 1.5 mL (150 units) reconstitution solution per 30 mg vial. See the reconstitution calculator for the arithmetic. This page does not provide dosing guidance.
For educational and research purposes only. This content is not medical advice. Compounds referenced are research use only and not intended to diagnose, treat, cure, or prevent any disease. Free Peptide University does not sell compounds.